IP Verse

Nucleic Acid Vaccines

Patent No. EP4023249 (titled "Nucleic Acid Vaccines") was filed by Moderna on Apr 23, 2015. The application was issued on Oct 9, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIONTECHJul 9, 2025WILK
PFIZERJul 4, 2025PFIZER
SANOFIMar 3, 2025CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4023249

MODERNA
Application Number
EP21195046A
Filing Date
Apr 23, 2015
Status
Granted And Under Opposition
Sep 6, 2024
Publication Date
Oct 9, 2024
External Links
Slate, Register , Google Patents